Biocept, Inc. (NASDAQ:BIOC)
About the company
Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell enrichment and extraction technology for the detection and analysis of circulating tumor DNA tests. It also offers services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies and clinical trial support and specific oncogenic alterations. Biocept was founded on May 12, 1997 and is headquartered in San Diego, CA.
Gross Margin (in %)
Operating Margin (in %)
Net Margin (in %)
Dividend Yield (in %)
|Name||Ticker||Market capitalization (in USD Million)||Revenues (in USD Million)||Price/Book||Price/Earning||Net margin (in %)|
|Guardant Health, Inc.||GH||7770.15||245.00||10.52||-100.66||-31.53|
|LHC Group, Inc.||LHCG||5518.93||2091.00||3.93||56.16||4.73|
|1Life Healthcare, Inc.||ONEM||4576.32||292.00||9.84||-57.65||-27.31|
|The Ensign Group, Inc.||ENSG||2381.12||2155.00||3.38||19.24||5.76|
|Acadia Healthcare Co., Inc.||ACHC||2210.56||3130.00||0.91||19.63||3.61|
|Addus HomeCare Corp.||ADUS||1289.96||598.00||3.05||62.68||3.33|
|U.S. Physical Therapy, Inc.||USPH||1051.18||478.00||4.31||35.78||6.03|
|Castle Biosciences, Inc.||CSTL||665.04||61.00||7.72||652.00||9.75|
|The Pennant Group, Inc.||PNTG||640.64||352.00||8.38||152.53||1.19|
|Option Care Health, Inc.||OPCH||636.00||2539.00||2.69||-6.50||-3.63|
|Tivity Health, Inc.||TVTY||540.00||1255.00||70.31||-1.09||-38.98|
|Fulgent Genetics, Inc.||FLGT||324.20||35.00||4.32||-1621.00||-1.31|
|American Renal Associates Holdings, Inc.||ARA||205.12||824.00||-2.54||-11.45||-2.19|
|CRH Medical Corp.||CRHM||164.62||117.00||2.17||112.75||1.52|
|Guardion Health Sciences, Inc.||GHSI||36.63||1.00||2.69||-1.60||-824.43|
|Cardiff Oncology, Inc.||CRDF||33.32||0.00||13.60||-2.17||-883.77|
|OncoSec Medical, Inc.||ONCS||26.00||None||2.13||-0.69||None|
|Capital Senior Living Corp.||CSU||21.36||439.00||-0.68||-0.31||-16.00|
|American Shared Hospital Services||AMS||12.42||20.00||0.45||51.75||1.28|
|IMAC Holdings, Inc.||IMAC||10.98||16.00||1.26||-1.63||-42.30|
Latest insider transactions
|Date||Role||Name||Transaction||Quantity||Quantity Owned After|
BIOCEPT AWARDED CANADIAN PATENT COVERING THE ENHANCED DETECTION OF RARE CELLS, INCLUDING CANCER CELLS, FROM A BIOLOGICAL FLUID SAMPLE SUCH AS BLOOD OR CEREBROSPINAL FLUID * BIOCEPT INC - AWARDED ...
Biocept Inc (NASDAQ:BIOC) shares gapped up before the market opened on Tuesday . The stock had previously closed at $0.75, ...
Biocept Enters Into Agreement with Reference-based Pricing Network Medical Cost Containment Professionals, LLC to Process Out-of-Network Claims
Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with ...
PRNewswire/ -- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide ...
Biocept receives Canadian patent entitled methods and reagents for signal amplification: San Diego Thursday, July 2, 2020, 15:00 Hrs [IST] Biocept Inc, a leading commercial provid ...
Collected specimens will be shipped overnight to Biocept's San Diego lab with results returned to ordering physicians within 24 to 48 hours CEO Nall said the company expects its RT-PCR COVID-19 kits ...
The micro-cap has manufactured 10,000 nasopharangeal swab collection kits, which will be available by 3Q to conduct PCR ...